Literature DB >> 12941768

Immunologic activity in the small intestinal mucosa of pediatric patients with type 1 diabetes.

Mia Westerholm-Ormio1, Outi Vaarala, Päivi Pihkala, Jorma Ilonen, Erkki Savilahti.   

Abstract

Involvement of gut immune system has been implicated in the pathogenesis of type 1 diabetes. However, few studies have been performed on the gut mucosa from patients with type 1 diabetes. Thus, we characterized the stage of immune activation in jejunal biopsy samples from 31 children with type 1 diabetes by immunohistochemistry, in situ hybridization, and RT-PCR. We found enhanced expressions of HLA-DR, HLA-DP, and intercellular adhesion molecule-1 by immunohistochemistry even on structurally normal intestine of patients with type 1 diabetes and no signs of celiac disease. In addition, the densities of IL-1 alpha- and IL-4-positive cells detected by immunohistochemistry and IL-4 mRNA-expressing cells evaluated by in situ hybridization were increased in the lamina propria in patients with type 1 diabetes and normal mucosa. Instead, the densities of IL-2, gamma-interferon (IFN-gamma), and tumor necrosis factor alpha-positive cells, the density of IFN-gamma mRNA positive cells, and the amounts of IFN-gamma mRNA detected by RT-PCR correlated with the degree of celiac disease in patients with type 1 diabetes. Our study supports the hypothesis that a link exists between the gut immune system and type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941768     DOI: 10.2337/diabetes.52.9.2287

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  54 in total

Review 1.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

2.  Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes.

Authors:  Chiara Sorini; Marika Falcone
Journal:  Am J Clin Exp Immunol       Date:  2013-06-15

Review 3.  Celiac disease in type 1 diabetes mellitus.

Authors:  Maria Erminia Camarca; Enza Mozzillo; Rosa Nugnes; Eugenio Zito; Mariateresa Falco; Valentina Fattorusso; Sara Mobilia; Pietro Buono; Giuliana Valerio; Riccardo Troncone; Adriana Franzese
Journal:  Ital J Pediatr       Date:  2012-03-26       Impact factor: 2.638

Review 4.  Gut microbiota and type 1 diabetes.

Authors:  Outi Vaarala
Journal:  Rev Diabet Stud       Date:  2012-12-28

5.  Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes.

Authors:  Wahiba Sakly; Amani Mankaï; Nabil Sakly; Yosra Thabet; Achouak Achour; Leila Ghedira-Besbes; Moncef Jeddi; Ibtissem Ghedira
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

6.  Wheat protein-induced proinflammatory T helper 1 bias in mesenteric lymph nodes of young diabetes-prone rats.

Authors:  H Chakir; D E Lefebvre; H Wang; E Caraher; F W Scott
Journal:  Diabetologia       Date:  2005-07-08       Impact factor: 10.122

7.  Detection of enteroviruses in the intestine of type 1 diabetic patients.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; S Oikarinen; K Vuori; K Kaukinen; I Rantala; M Mäki; H Hyöty
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

8.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

9.  Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine.

Authors:  Mariantonia Maglio; Fiorella Florian; Monica Vecchiet; Renata Auricchio; Francesco Paparo; Raffaella Spadaro; Delia Zanzi; Luciano Rapacciuolo; Adriana Franzese; Daniele Sblattero; Roberto Marzari; Riccardo Troncone
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

10.  Diabetes-specific HLA-DR-restricted proinflammatory T-cell response to wheat polypeptides in tissue transglutaminase antibody-negative patients with type 1 diabetes.

Authors:  Majid Mojibian; Habiba Chakir; David E Lefebvre; Jennifer A Crookshank; Brigitte Sonier; Erin Keely; Fraser W Scott
Journal:  Diabetes       Date:  2009-04-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.